Cardiovascular Risk Stratification in Patients With Obstructive Sleep Apnea
ERA
1 other identifier
observational
2,000
1 country
1
Brief Summary
The purpose of this study is:
- 1.To determine the frequency of cardiovascular diseases in patients with OSA, obese, overweight, and lean (BMI\<25)
- 2.To analyze the CPAP treatment over the clinical evolution of OSA patients
- 3.To determine if OSA is a independent predictor of cardiovascular risk
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2005
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2005
CompletedFirst Submitted
Initial submission to the registry
October 7, 2008
CompletedFirst Posted
Study publicly available on registry
October 8, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedOctober 8, 2008
October 1, 2008
5.9 years
October 7, 2008
October 7, 2008
Conditions
Outcome Measures
Primary Outcomes (1)
Cardiovascular events
five years
Eligibility Criteria
1000 OSA patients and 1000 controls enrolled from Instituto do Sono database 500 subjects with body mass index less than 25
You may qualify if:
- Men and women with OSA (apnea-hypopnea index higher than 5 events/hour)
You may not qualify if:
- Body mass index higher than 40
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Instituto do Sono/AFIP
São Paulo, São Paulo, 04516001, Brazil
Related Publications (3)
Feres MC, Fonseca FA, Cintra FD, Mello-Fujita L, de Souza AL, De Martino MC, Tufik S, Poyares D. An assessment of oxidized LDL in the lipid profiles of patients with obstructive sleep apnea and its association with both hypertension and dyslipidemia, and the impact of treatment with CPAP. Atherosclerosis. 2015 Aug;241(2):342-9. doi: 10.1016/j.atherosclerosis.2015.05.008. Epub 2015 May 23.
PMID: 26071656DERIVEDCintra FD, Tufik S, Paola Ad, Feres MC, Melo-Fujita L, Oliveira W, Rizzi C, Poyares D. Cardiovascular profile in patients with obstructive sleep apnea. Arq Bras Cardiol. 2011 Apr;96(4):293-9. doi: 10.1590/s0066-782x2011005000030. Epub 2011 Mar 18. English, Portuguese, Spanish.
PMID: 21437515DERIVEDRizzi CF, Cintra F, Risso T, Pulz C, Tufik S, de Paola A, Poyares D. Exercise capacity and obstructive sleep apnea in lean subjects. Chest. 2010 Jan;137(1):109-14. doi: 10.1378/chest.09-1201. Epub 2009 Oct 3.
PMID: 19801583DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fatima D Cintra, PhD
Associacao Fundo de Incentivo a Psicofarmcologia
- STUDY CHAIR
Dalva Poyares, PhD
Associacao Fundo de Incentivo a Psicofarmcologia
- STUDY DIRECTOR
Sergio Tufik, PhD
Associacao Fundo de Incentivo a Psicofarmcologia
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
October 7, 2008
First Posted
October 8, 2008
Study Start
April 1, 2005
Primary Completion
March 1, 2011
Study Completion
December 1, 2012
Last Updated
October 8, 2008
Record last verified: 2008-10